(Q44614090)

4 December 2017

title

Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity (English)

1 reference

4 December 2017

Effects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on Antigenicity (English)

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

23 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

23 December 2023

4

Joseph Sodroski

1 reference

4 December 2017

Zhihai Si

1

1 reference

4 December 2017

Ngoc Phan

2

1 reference

4 December 2017

Enko Kiprilov

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689414

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

4 December 2017

http://www.liebertpub.com/doi/pdf/10.1089/088922203763315722

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

AIDS Research and Human Retroviruses

23 December 2023

published in

1 reference

4 December 2017

volume

19

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

217-226

1 reference

Identification of a major co-receptor for primary isolates of HIV-1

4 December 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/381661A0

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

1

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Crystal structure of SIV matrix antigen and implications for virus assembly

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Atomic structure of a thermostable subdomain of HIV-1 gp41

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Atomic structure of the ectodomain from HIV-1 gp41

23 December 2023

9

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

HIV-1 entry inhibitors in the side pocket

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Mechanisms of viral membrane fusion and its inhibition

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The antigenic structure of the HIV gp120 envelope glycoprotein

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

A vaccine for HIV type 1: the antibody perspective

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

23 December 2023

27

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

23 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization

23 December 2023

33

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Expression, purification, and characterization of gp160e, the soluble, trimeric ectodomain of the simian immunodeficiency virus envelope glycoprotein, gp160.

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Journal of Acquired Immune Deficiency Syndromes

23 December 2023

43

5

639

Li J

1992

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques

23 December 2023

45

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).

23 December 2023

46

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

23 December 2023

47

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys

23 December 2023

48

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques

23 December 2023

50

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS.

23 December 2023

51

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism

23 December 2023

52

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)

23 December 2023

53

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

23 December 2023

54

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor

23 December 2023

55

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

23 December 2023

56

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Journal of Acquired Immune Deficiency Syndromes

23 December 2023

57

6

7

Posner MR

1993

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

23 December 2023

59

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

23 December 2023

60

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo

23 December 2023

61

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation

23 December 2023

62

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

23 December 2023

63

1 reference

https://api.crossref.org/works/10.1089/088922203763315722

23 December 2023

Identifiers

1 reference

4 December 2017

1 reference